United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 1 mg in 1 g - triamcinolone acetonide cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.  triamcinolone acetonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

versapharm incorporated - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.147 mg in 1 g - triamcinolone acetonide topical aerosol, usp is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone - unii:1zk20vi6ty) - triamcinolone acetonide 55 ug - triamcinolone acetonide nasal spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older. labeling describing use of triamcinolone acetonide nasal spray in pediatric patients 2 to 5 years of age is approved for sanofi-aventis u.s. inc.’s nasacort® aq nasal spray. however, due to sanofi-aventis u.s. inc.’s marketing exclusivity rights, a description of that use is not approved for this triamcinolone acetonide nasal spray labeling. triamcinolone acetonide should not be administered to patients with a history of hypersensitivity to triamcinolone acetonide or to any of the other ingredients of this preparation. there are no adequate and well-controlled studies of triamcinolone acetonide nasal spray in pregnant women. triamcinolone acetonide was teratogenic in rats, rabbits, and monkeys. triamcinolone acetonide nasal spray, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies

United States - English - NLM (National Library of Medicine)

medvantx, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone - unii:1zk20vi6ty) - triamcinolone acetonide 55 ug - triamcinolone acetonide nasal spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older. labeling describing use of triamcinolone acetonide nasal spray in pediatric patients 2 to 5 years of age is approved for sanofi-aventis u.s. inc.’s nasacort® aq nasal spray. however, due to sanofi-aventis u.s. inc.’s marketing exclusivity rights, a description of that use is not approved for this triamcinolone acetonide nasal spray labeling. triamcinolone acetonide should not be administered to patients with a history of hypersensitivity to triamcinolone acetonide or to any of the other ingredients of this preparation. there are no adequate and well-controlled studies of triamcinolone acetonide nasal spray in pregnant women. triamcinolone acetonide was teratogenic in rats, rabbits, and monkeys. triamcinolone acetonide nasal spray, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.25 mg in 1 ml - triamcinolone acetonide lotion usp, 0.025% and 0.1% are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 1 mg in 1 g - triamcinolone acetonide cream usp, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 1 mg in 1 g - triamcinolone acetonide ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 1 mg in 1 g - triamcinolone acetonide ointment 0.1% and 0.5% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.25 mg in 1 g - triamcinolone acetonide cream usp contains triamcinolone acetonide [pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis- (oxy)]-, (11β,16α)-], with the empirical formula c 24 h 31 fo 6 and molecular weight 434.50. cas 76-25-5. triamcinolone acetonide cream usp 0.025% contains: 0.25 mg of triamcinolone acetonide usp per gram in a water washable cream base consisting of  mineral oil (and) lanolin alcohol, isopropyl palmitate nf, propylene glycol stearate, propylene glycol usp, cetyl alcohol nf, sorbitan monostearate nf, polysorbate 60 nf, sorbic acid nf, polyoxyl (40) stearate nf, propylparaben nf, methylparaben nf and purified water usp. triamcinolone acetonide cream usp 0.1% contains: 1 mg of triamcinolone acetonide usp per gram in a water washable cream base consisting of  mineral oil (and) lanolin alcohol, isopropyl palmitate nf, propylene glycol stearate, propylene glycol usp, cetyl alcohol nf, sorbitan monostearate nf,

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 1 mg in 1 g - triamcinolone acetonide dental paste usp, 0.1% is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma. triamcinolone acetonide dental paste is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation; it is also contraindicated in the presence of fungal, viral, or bacterial infections of the mouth or throat.